lobbying_activities: 2591399

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2591399	b2a1dc44-269f-42cb-9601-6bda4f01dd35	Q1	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2021	first_quarter	HCR	On January 27, AACC wrote to the White House Pandemic Board raising issues pertaining to lab supply shortages involving COVID-19 testing and offering assistance. On February 2, AACC submitted a statement to the House Energy and Commerce Committee raising concerns about lab supply shortages pertaining to COVID-19 testing. On February 2, AACC wrote to House and Senate leaders expressing concerns about ongoing shortages of supplies needed to perform COVID-19 testing On February 15, AACC wrote to Rep. Roybal-Allard endorsing H.R482, the Newborn Screening Saves Lives Reauthorization Act On March 8, AACC wrote to Senator Paul endorsing the Verified Innovative Testing in American Laboratories Act On March 15, AACC wrote to Senator Hassan endorsing S.350, the Newborn Screening Saves Lives Reauthorization Act	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE		80000	0	0	2021-04-01T10:59:22.697000-04:00